Wentao Yang
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 55
- Cancer Genomics and Diagnostics 19
- Oncology 80
- HER2/EGFR in Cancer Research 31
- Cancer Cells and Metastasis 16
- Cancer Immunotherapy and Biomarkers 12
Wentao Yang
164 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 120
- Cancer Research 1.2k
- Oncology 1.7k
- Reproductive Medicine 281
- Pathology and Forensic Medicine 553
- Dermatology 205
Countries citing papers authored by Wentao Yang
This map shows the geographic impact of Wentao Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wentao Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wentao Yang more than expected).
Fields of papers citing papers by Wentao Yang
This network shows the impact of papers produced by Wentao Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wentao Yang. The network helps show where Wentao Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wentao Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 66 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 32 | |
| 8 | 2023 | 37 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 16 | |
| 12 | 2019 | 265 | |
| 13 | 2018 | 4 | |
| 14 | 2017 | 9 | |
| 15 | 2017 | 6 | |
| 16 | 2013 | 5 | |
| 17 | 2009 | 158 | |
| 18 | 2008 | 73 | |
| 19 | Clinical studies on early postoperative enteral nutrition in patients with esophageal cancer | 2003 | 1 |
| 20 | Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells. | 2002 | 93 |
About Wentao Yang
Wentao Yang is a scholar working on Cancer Research, Oncology, Reproductive Medicine, Pathology and Forensic Medicine and Dermatology, having authored 173 papers that have together received 3.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (55 papers), Breast Lesions and Carcinomas (40 papers), HER2/EGFR in Cancer Research (31 papers), Ovarian cancer diagnosis and treatment (22 papers), Cancer Genomics and Diagnostics (19 papers), Cancer and Skin Lesions (17 papers), Cancer Cells and Metastasis (16 papers) and Cancer Immunotherapy and Biomarkers (12 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.7k citations), Reproductive Medicine (281 citations), Pathology and Forensic Medicine (553 citations) and Dermatology (205 citations). Wentao Yang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Dihua Yu, Rui Bi, Xiaoyan Zhou, Kristine S. Klos, Shuling Zhou, Ruohong Shui, Xiaohua Wu, Baohua Yu, Daren Shi and Zheng Feng. Their work appears in journals such as Diagnostic Pathology, Histopathology, Oncotarget, Cancer Research and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.